PO:20:007 | Mind the rebound: ctx dynamics after denosumab discontinuation and zoledronate rescue in patients with postmenopausal osteoporosis or with cancer treatment-induced bone loss: Federico Aldegheri1, Francesca Ruzzon1, Matteo Appoloni1, Giovanni Adami1, Davide Gatti1, Maurizio Rossini1, Angelo Fassio1, Ombretta Viapiana1 | 1Università di Verona, Italy. Reumatismo [Internet]. 2026 Mar. 18 [cited 2026 Apr. 30];77(s1). Available from: https://www.reumatismo.org/reuma/article/view/2342